Literature DB >> 2991580

Purification of a HeLa cell receptor protein for group B coxsackieviruses.

J E Mapoles, D L Krah, R L Crowell.   

Abstract

Coxsackievirus B3 (CB3) firmly attaches to HeLa cells, forming a specific complex between the virus and its receptor on the cell surface. We extracted this virus-receptor complex (VRC) with the detergents sodium deoxycholate and Triton X-100. The VRC was identified by its sedimentation coefficient (140S), which was less than that of virions (155S). Formation of the VRC from cell lysates and 3H-CB3 occurred with the same specificity as did attachment of virions to cells, in that its formation was blocked by unlabeled CB3 but not by poliovirus. The VRC was purified 30,000-fold by differential and sucrose gradient centrifugation. Iodination with Na125I revealed that the purified VRC consisted of the normal CB3 proteins and one additional protein (RP-a) with an approximate molecular weight of 49,500. RP-a was eluted from the VRC and was shown to rebind with CB3 and CB1 virions but not with poliovirus type 1. We propose that Rp-a is a protein in the plasma membrane receptor complex which is responsible for the specific recognition and binding of the group B coxsackieviruses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991580      PMCID: PMC255009     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Early alteration of poliovirus in infected cells and its specific inhibition.

Authors:  K Lonberg-Holm; L B Gosser; J C Kauer
Journal:  J Gen Virol       Date:  1975-06       Impact factor: 3.891

2.  Unrelated animal viruses share receptors.

Authors:  K Lonberg-Holm; R L Crowell; L Philipson
Journal:  Nature       Date:  1976-02-26       Impact factor: 49.962

3.  The use of sodium dodecyl sulfate in studies on the interaction of poliovirus and HeLa cells.

Authors:  B MANDEL
Journal:  Virology       Date:  1962-06       Impact factor: 3.616

4.  Properties of the deoxycholate-solubilized HeLa cell plasma membrane receptor for binding group B coxsackieviruses.

Authors:  D L Krah; R L Crowell
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Differential inhibition of attachment and eclipse activities of HeLa cells for enteroviruses.

Authors:  I Zajac; R L Crowell
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Monoclonal antibodies which block cellular receptors of poliovirus.

Authors:  P D Minor; P A Pipkin; D Hockley; G C Schild; J W Almond
Journal:  Virus Res       Date:  1984       Impact factor: 3.303

8.  A solid-phase assay of solubilized HeLa cell membrane receptors for binding group B coxsackieviruses and polioviruses.

Authors:  D L Krah; R L Crowell
Journal:  Virology       Date:  1982-04-15       Impact factor: 3.616

9.  A sialoglycopeptide from human erythrocytes with receptor-like properties for encephalomyocarditis and influenza viruses.

Authors:  A T Burness; I U Pardoe
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

10.  Specific alterations of coxsackievirus B3 eluted from HeLa cells.

Authors:  R L Crowell; L Philipson
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

View more
  25 in total

1.  Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers.

Authors:  D R Anderson; C M Carthy; J E Wilson; D Yang; D V Devine; B M McManus
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  mRNA translation is compartmentalized to the endoplasmic reticulum following physiological inhibition of cap-dependent translation.

Authors:  Rachel S Lerner; Christopher V Nicchitta
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

3.  Neutralization activity of some Coxsackie B3 antibodies is compromised by protein factor(s) secreted by Vero cells.

Authors:  K Konishi; M Kawabata; K Ohtaki
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 4.  Strategies for the identification of icosahedral virus receptors.

Authors:  D M Bass; H B Greenberg
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

5.  Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment.

Authors:  D R Shafren; R C Bates; M V Agrez; R L Herd; G F Burns; R D Barry
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 6.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Improved adenovirus vectors for infection of cardiovascular tissues.

Authors:  M J Havenga; A A Lemckert; J M Grimbergen; R Vogels; L G Huisman; D Valerio; A Bout; P H Quax
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

8.  Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.

Authors:  S L Highlander; S L Sutherland; P J Gage; D C Johnson; M Levine; J C Glorioso
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

9.  A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.

Authors:  K H Hsu; K Lonberg-Holm; B Alstein; R L Crowell
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

Review 10.  The pathogenetic basis of viral tropism.

Authors:  C A Mims
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.